Aurobindo arm Lannett’s facility in U.S. gets 4 U.S. FDA observations
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
· 8/25/2026, 11:22:12 AM· 2 min read
Lannett’s Seymour manufacturing facility has the capacity to scale production to approximately 4 billion doses annually.
Read original story →Related stories
business
Dr. Reddy’s CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
business
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
business
Commodity costs, geopolitical tensions threaten to derail India Inc.’s Q2 earnings momentum: Brokerages
business